480 related articles for article (PubMed ID: 28406726)
21. Influence of aflibercept on platelet activation profile.
Sobolewska B; Golenko J; Poeschel S; Grimmel C; Gatsiou A; Sopova K; Biedermann T; Schenke-Layland K; Stellos K; Ziemssen F
Exp Eye Res; 2018 Oct; 175():166-172. PubMed ID: 29908884
[TBL] [Abstract][Full Text] [Related]
22. Morin hydrate inhibits platelet activation and clot retraction by regulating integrin α
Nam GS; Lee KS; Nam KS
Eur J Pharmacol; 2019 Dec; 865():172734. PubMed ID: 31614139
[TBL] [Abstract][Full Text] [Related]
23. Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice.
Niki M; Nayak MK; Jin H; Bhasin N; Plow EF; Pandolfi PP; Rothman PB; Chauhan AK; Lentz SR
Thromb Haemost; 2016 May; 115(5):969-78. PubMed ID: 26790499
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia impairs agonist-induced integrin α
Kiouptsi K; Gambaryan S; Walter E; Walter U; Jurk K; Reinhardt C
Sci Rep; 2017 Aug; 7(1):7621. PubMed ID: 28790378
[TBL] [Abstract][Full Text] [Related]
26. Effect of alteplase on platelet function and receptor expression.
Lu J; Hu P; Wei G; Luo Q; Qiao J; Geng D
J Int Med Res; 2019 Apr; 47(4):1731-1739. PubMed ID: 30799665
[TBL] [Abstract][Full Text] [Related]
27. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
28. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
29. Binding of plasma factor XIII to thrombin-receptor activated human platelets.
Nagy B; Simon Z; Bagoly Z; Muszbek L; Kappelmayer J
Thromb Haemost; 2009 Jul; 102(1):83-9. PubMed ID: 19572072
[TBL] [Abstract][Full Text] [Related]
30. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
31. Conformation-Specific Blockade of αIIbβ3 by a Non-RGD Peptide to Inhibit Platelet Activation without Causing Significant Bleeding and Thrombocytopenia.
Shen C; Liu M; Tian H; Li J; Xu R; Mwangi J; Lu Q; Hao X; Lai R
Thromb Haemost; 2020 Oct; 120(10):1432-1441. PubMed ID: 32717755
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Integrin αIIbβ3-Mediated Outside-in Signaling by Protein Kinase Cδ in Platelets.
Chaudhary PK; Kim S; Jee Y; Lee SH; Kim S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911704
[TBL] [Abstract][Full Text] [Related]
33. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
34. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
[TBL] [Abstract][Full Text] [Related]
35. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
36. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
[TBL] [Abstract][Full Text] [Related]
38. Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses.
Gabbeta J; Yang X; Kowalska MA; Sun L; Dhanasekaran N; Rao AK
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8750-5. PubMed ID: 9238049
[TBL] [Abstract][Full Text] [Related]
39. Distinct role of Pyk2 in mediating thromboxane generation downstream of both G12/13 and integrin αIIbβ3 in platelets.
Kim S; Cipolla L; Guidetti G; Okigaki M; Jin J; Torti M; Kunapuli SP
J Biol Chem; 2013 Jun; 288(25):18194-203. PubMed ID: 23640884
[TBL] [Abstract][Full Text] [Related]
40. Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase-dependent calcium stores.
Elaïb Z; Adam F; Berrou E; Bordet JC; Prévost N; Bobe R; Bryckaert M; Rosa JP
Blood; 2016 Aug; 128(8):1129-38. PubMed ID: 27301859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
